Literature DB >> 19779664

Has the Partington procedure for chronic pancreatitis become a thing of the past? A review of the evidence.

Shuji Isaji1.   

Abstract

INTRODUCTION: For the surgical management of chronic pancreatitis with an inflammatory pancreatic head mass, extended drainage operations such as Beger and Frey procedures were established in the 1980s as an alternative to resectional procedures like pancreaticoduodenectomy and as opposed to simple drainage operations such as lateral pancreaticojejunostomy, that is, the Partington procedure. With the relatively rapid adoption of the two procedures, it seems that the Partington procedure has become a thing of the past.
MATERIALS AND METHODS: The Partington procedure was re-evaluated with regard to the historical aspects and its present status by a literature review.
RESULTS: The results show that this procedure relieves chronic abdominal pain in 66-91% of patients with a mean follow-up of 3.5-9.1 years. It is important to note that this procedure is generally used for inflammatory disease left of the gastroduodenal artery and is specifically not used as the procedure of choice for inflammatory disease of the pancreatic head.
CONCLUSION: For patients with a dilated main pancreatic duct but without an inflammatory pancreatic head mass, the Partington procedure is still the procedure of choice, since it is technically simple to perform with a minimum of morbidity and mortality, preserving pancreatic endocrine and exocrine function. Because it is a relatively simple technique, the laparoscopic approach will be justified as a treatment of appropriate patients in the near future.

Entities:  

Mesh:

Year:  2009        PMID: 19779664     DOI: 10.1007/s00534-009-0181-8

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Sci        ISSN: 1868-6974            Impact factor:   7.027


  7 in total

1.  Longitudinal pancreaticogastrostomy in patients with chronic pancreatitis.

Authors:  Laureano Fernández-Cruz; José-Ignacio Poves; Santiago Sánchez; Luis Grande; Jorge Ordóñez
Journal:  HPB (Oxford)       Date:  2014-09-23       Impact factor: 3.647

2.  Evaluation of Pain Preoperatively and Postoperatively in Patients with Chronic Pancreatitis Undergoing Longitudinal Pancreaticojejunostomy.

Authors:  K R Seetharam Bhat; Monty Khajanchi; Ram Prajapati; R R Satoskar
Journal:  Indian J Surg       Date:  2014-10-11       Impact factor: 0.656

3.  Role of original and modified Frey's procedures in chronic pancreatitis.

Authors:  Chun-Lu Tan; Hao Zhang; Min Yang; Shao-Jun Li; Xu-Bao Liu; Ke-Zhou Li
Journal:  World J Gastroenterol       Date:  2016-12-21       Impact factor: 5.742

4.  Improved quality of life following total pancreatectomy and auto-islet transplantation for chronic pancreatitis.

Authors:  R M Walsh; J R Aguilar Saavedra; G Lentz; A D Guerron; J Scheman; T Stevens; M Trucco; R Bottino; B Hatipoglu
Journal:  J Gastrointest Surg       Date:  2012-06-07       Impact factor: 3.452

5.  Is endoscopic therapy the treatment of choice in all patients with chronic pancreatitis?

Authors:  Beata Jabłońska
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

6.  Chronic pancreatitis: Multicentre prospective data collection and analysis by the Hungarian Pancreatic Study Group.

Authors:  Ákos Szücs; Tamás Marjai; Andrea Szentesi; Nelli Farkas; Andrea Párniczky; György Nagy; Balázs Kui; Tamás Takács; László Czakó; Zoltán Szepes; Balázs Csaba Németh; Áron Vincze; Gabriella Pár; Imre Szabó; Patrícia Sarlós; Anita Illés; Szilárd Gódi; Ferenc Izbéki; Judit Gervain; Adrienn Halász; Gyula Farkas; László Leindler; Dezső Kelemen; Róbert Papp; Richárd Szmola; Márta Varga; József Hamvas; János Novák; Barnabás Bod; Miklós Sahin-Tóth; Péter Hegyi
Journal:  PLoS One       Date:  2017-02-16       Impact factor: 3.240

7.  Drainage procedure for pancreatolithiasis: re-examination of the pancreatic duct diameter standard.

Authors:  Guoyong Chen; Yu You; Hongxian Yan; Junchuang He; Jianping Gong; Sidong Wei
Journal:  Ann Surg Treat Res       Date:  2020-03-31       Impact factor: 1.859

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.